Research study Program year 2020 Source: CMS Open Payments

M15-550

ClinicalTrials.gov NCT02756611

Research payments

$173,026

76 payments

Through program year 2020, $173,026 in research payments was reported against M15-550, across 76 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: NCT02756611

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$97,165	30
2019	Research	$75,861	46

Breakdown

Who paid Research payments · program years 2019–2020

AbbVie, Inc. $173,026 76 payments

Who received the money Research payments · program years 2019–2020

P R Hematology Oncology Group INC Organisation paid for research $77,452 9 payments
Norton Healthcare INC Organisation paid for research $41,041 32 payments
Hackensack University Medical Center Teaching hospital · NJ $22,360 8 payments
Utah Cancer Specialists Organisation paid for research $22,223 17 payments
West Virginia University Research Organisation paid for research $3,744 4 payments
St. Agnes Hospital Teaching hospital · MD $2,547 3 payments
Parameswa Venugopal Hematology · Chicago, IL $2,400 2 payments
Brian Link Hematology & Oncology · Iowa City, IA $1,260 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

7 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.